Leishmania MAP kinases--familiar proteins in an unusual context.
about
mitogen-activated protein kinase, putativemitogen-activated protein kinase, putativemitogen-activated protein kinase, putativemitogen activated protein kinase, putativemitogen-activated protein kinase, putativemitogen-activated protein kinase 2mitogen-activated protein kinase, putativemitogen-activated protein kinase 2Mitogen-activated protein kinase 8, putativemitogen-activated protein kinase, putativemitogen-activated protein kinase, putativemitogen activated protein kinase, putativemitogen-activated protein kinasemitogen-activated protein kinase, putativemitogen-activated protein kinase, putativemitogen-activated protein kinase, putativemitogen activated protein kinase, putativemitogen-activated protein kinase, putativemitogen-activated protein kinase 2mitogen-activated protein kinase 2mitogen-activated protein kinase, putativemitogen-activated protein kinase, putativemitogen-activated protein kinase, putativemitogen activated protein kinase, putativemitogen-activated protein kinase, putativemitogen-activated protein kinase 2
P1343
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistanceLeishmania carbon metabolism in the macrophage phagolysosome- feast or famine?Kinases as druggable targets in trypanosomatid protozoan parasitesThe TriTryp phosphatome: analysis of the protein phosphatase catalytic domains2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approachInfectivity of Leishmania mexicana is associated with differential expression of protein kinase C-like triggered during a cell-cell contactLeishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage.Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability.Molecular cloning and characterization of mitogen-activated protein kinase 2 in Trypanosoma cruziHuman p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationStructures, targets and recent approaches in anti-leishmanial drug discovery and development.Identity crisis? The need for systematic gene IDs.Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase.Leishmania adaptor protein-1 subunits are required for normal lysosome traffic, flagellum biogenesis, lipid homeostasis, and adaptation to temperatures encountered in the mammalian host.Leishmania sand fly interaction: progress and challenges.Distinct roles of a mitogen-activated protein kinase in cytokinesis between different life cycle forms of Trypanosoma brucei.Central carbon metabolism of Leishmania parasites.Drug resistance in leishmaniasis: Newer developments.Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens.What has proteomics taught us about Leishmania development?Osmosensing and osmoregulation in unicellular eukaryotes.A touch of Zen: post-translational regulation of the Leishmania stress response.Linear B-cell epitope mapping of MAPK3 and MAPK4 from Leishmania braziliensis: implications for the serodiagnosis of human and canine leishmaniasis.Catalytic activity of a novel serine/threonine protein phosphatase PP5 from Leishmania major.Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses.Identification and specific localization of tyrosine-phosphorylated proteins in Trypanosoma brucei.Homology modeling of LmxMPK4 of Leishmania mexicana and virtual screening of potent inhibitors against it.Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents.In Silico Elucidation and Inhibition Studies of Selected Phytoligands Against Mitogen-Activated Protein Kinases of Protozoan Parasites.Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.Joining forces: first application of a rapamycin-induced dimerizable Cre system for conditional null mutant analysis in Leishmania.
P2860
Q61498412-2900C1F3-A187-48B3-A2B7-17367B6029D1Q61530525-239285EC-597D-41D6-817A-A6B301ACD8E2Q61536814-F0F7BEAF-645F-4D8F-B5E4-7EE300FE2DF1Q61538855-3095A7FB-6340-4E42-B581-03F13CBFBAD8Q61548210-D39C91D4-8C43-4C3B-AD10-04956F56F540Q61549145-89192285-251D-453C-AAFE-A4D1E87049A9Q62137097-89A33AF8-558C-4B51-BA8D-DD0EBEFFDFE9Q62139489-48E67343-4463-406B-A37E-5F570883771BQ62149616-4DF04136-EC45-4D38-BDA6-8E523A998E08Q62151873-40F80947-816C-4277-A976-0BC5EC1DAECCQ62155022-98EF35A6-0801-4F90-9056-37B953643CF7Q62155911-5A705738-2AB7-4FD9-A36B-E40175FE9E2DQ62160507-B7A73BFD-CB0C-4FFD-BF86-A1E72D10F7E2Q62420211-C56D2C1E-6393-4211-B214-62EC21FAC700Q62429244-1D3CC9EA-C100-42D8-AA41-6188D3E4CF34Q62431355-1467868A-1D46-45E4-8FD5-7323E0245517Q62432226-908D700E-14A3-4658-85E9-63516A38AFC0Q62435121-A82D6D61-923A-43CD-B218-99135BCE3E69Q62435670-F517948F-ABC9-4E60-9CA4-43B01291E3E8Q62451999-3695DA4B-3CB2-4AA8-A0AE-E5B1D30BDA8AQ62455387-EECD6A75-4591-4F5B-807C-774B321C67ADQ62463662-8774EAD2-9A0A-4070-BF2D-AEC71F0E119BQ62465245-6DF58C76-0FB0-4A95-AF81-F0B2194B2ACAQ62465702-B47C69BA-4C67-41DC-BD1A-BEA942C1A581Q62468173-D6BA8B67-5D81-43D6-8FD8-FB5B5D2B5B72Q62468359-1B05A07D-4A4A-4E80-8A88-C0B91B741140
P1343
Q24633552-C2CC79F0-2885-4934-AA12-F781075EE549Q26776497-1C0BAA9B-FBCF-4A9B-ACE8-BA4FE85E23E8Q26786761-0E120CBC-CEB6-40C7-8DFA-1615CED8B81FQ28258708-744E97EB-E291-4B60-9F3D-187D2E21D3A4Q28477104-97E624FD-DE93-4800-A167-64AC3C533DA5Q33511990-6903D908-9ADF-4C47-9657-8CF699B7665EQ33585885-9647ABD9-9C47-422C-93CA-0A7D3B89F171Q34215427-D1E4444B-D28E-433D-AB49-5E041FEB59CDQ34582170-44C1EA8E-D967-4CD7-8903-3E42C75AD8B0Q34792290-B1FAABE8-4081-47E1-A655-2C8C41BBFF64Q35012968-E09C5746-B7C9-483B-AD53-0CC745836BFEQ35111856-CA4DD9E4-E0AD-4BE1-8A24-3AD3743596F7Q36223332-7C4C7DDC-0F2D-4D08-87A6-2C2A08169DBEQ36846221-7D2088F4-09DD-4CAA-A653-3946AA1FB9F8Q37175845-91DFE24C-0F75-4D3C-863A-6BBBE95D7030Q37545141-AB37537C-6255-4DA6-A07F-53896EAFCD1CQ37693229-FD8E2D39-B390-4FD3-BD05-81604C3EC90AQ37712190-72804C04-A43F-41EF-AC1E-8CD6FDF28FEDQ37884396-9C1C7C7A-500E-401D-B63B-D7C2FFA02695Q37988648-A185378F-407B-4AA2-8BFC-0119A6822B30Q38338893-0FF9C236-973F-4CC3-A910-6CA4AE9D99C1Q38388370-EABAC1C8-F6ED-4D02-B392-9857DBBD69ECQ38943658-0B321E97-95E2-4B67-B50E-147B391020CFQ39181812-96C583E6-E2BA-4EE2-9170-D62BDB2C8345Q40325470-7A5B62E4-BB1F-4161-94B8-F0F54C5200DEQ42219032-AD9EDF15-EFAA-4C29-9FE6-D87D4251A80EQ42448669-10A7A66D-6414-4F58-BB74-01D9BA8B930FQ46064089-7A40A1F4-34D2-4094-BDE8-20E88CE9AF53Q47884524-54FE3243-BF01-4CFD-A75E-373E742AF19EQ53828370-20351AC0-FF9B-489F-BBD5-7489BA5BF667Q54325937-C61A3E22-3E7E-4329-B462-E328619265A7Q55026574-24A77A1F-AB16-428F-94E4-B319AEAB8983
P2860
Leishmania MAP kinases--familiar proteins in an unusual context.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Leishmania MAP kinases--familiar proteins in an unusual context.
@en
Leishmania MAP kinases--familiar proteins in an unusual context.
@nl
type
label
Leishmania MAP kinases--familiar proteins in an unusual context.
@en
Leishmania MAP kinases--familiar proteins in an unusual context.
@nl
prefLabel
Leishmania MAP kinases--familiar proteins in an unusual context.
@en
Leishmania MAP kinases--familiar proteins in an unusual context.
@nl
P921
P1476
Leishmania MAP kinases--familiar proteins in an unusual context.
@en
P2093
Martin Wiese
P304
P356
10.1016/J.IJPARA.2007.04.008
P577
2007-04-29T00:00:00Z